Review
doi: 10.2169/internalmedicine.43.931.
Renal transplant recipient with chronic hepatitis C who obtained sustained viral response after interferon-beta therapy
Affiliations
- PMID: 15575242
- DOI: 10.2169/internalmedicine.43.931
Item in Clipboard
Review
Renal transplant recipient with chronic hepatitis C who obtained sustained viral response after interferon-beta therapy
Intern Med.
2004 Oct.
Free article
Abstract
A 44-year-old Japanese woman with a history of living-related renal transplantation was treated with interferon-beta (IFN-beta) for chronic infection with sero-group 2 hepatitis C virus (HCV). Serum HCV-RNA titer was 160 kilo-international units/ml. Treatment with intravenous IFN-beta daily was given for 6 weeks. Serum HCV-RNA was undetectable at 3 weeks after initiating therapy. Renal graft rejection did not occur. Six months after completing therapy, she obtained sustained viral response. This case demonstrates that IFN-beta therapy safely induced clearance of HCV in a renal transplant recipient with stable renal function, low viral load and/or HCV sero-group 2.
Similar articles
-
Chronic hepatitis C virus infection in renal transplant: treatment and outcome.Clin Transplant. 2006 Nov-Dec;20(6):677-83. doi: 10.1111/j.1399-0012.2006.00534.x. Clin Transplant. 2006. PMID: 17100715
-
A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta.Hepatology. 2001 Aug;34(2):377-84. doi: 10.1053/jhep.2001.26086. Hepatology. 2001. PMID: 11481623 Clinical Trial.
-
Factors associated with efficacy of pegylated interferon-α plus ribavirin for chronic hepatitis C after renal transplantation.Gene. 2014 Jul 10;544(2):101-6. doi: 10.1016/j.gene.2014.04.072. Epub 2014 May 1. Gene. 2014. PMID: 24793583 Review.
-
Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.Hepatogastroenterology. 2002 Sep-Oct;49(47):1373-6. Hepatogastroenterology. 2002. PMID: 12239945
-
Direct-acting antiviral therapy for hepatitis C virus infection in the kidney transplant recipient.Kidney Int. 2018 Mar;93(3):560-567. doi: 10.1016/j.kint.2017.10.024. Epub 2018 Jan 9. Kidney Int. 2018. PMID: 29325996 Review.
Cited by
-
Hepatitis C viral infection in patients with chronic kidney disease.Clin Liver Dis (Hoboken). 2012 Jul 23;1(3):91-94. doi: 10.1002/cld.55. eCollection 2012 Jul. Clin Liver Dis (Hoboken). 2012. PMID: 31186858 Free PMC article. No abstract available.
-
Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis.PLoS One. 2014 Apr 3;9(4):e90611. doi: 10.1371/journal.pone.0090611. eCollection 2014. PLoS One. 2014. PMID: 24699257 Free PMC article.
-
Infección por el virus de la hepatitis C en pacientes con enfermedad renal crónica.Clin Liver Dis (Hoboken). 2014 Jan 13;2(Suppl 5):65-68. doi: 10.1002/cld.276. eCollection 2013 Nov. Clin Liver Dis (Hoboken). 2014. PMID: 31333827 Free PMC article. Review. Spanish. No abstract available.
-
Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation.Can J Gastroenterol. 2006 Jun;20(6):427-31. doi: 10.1155/2006/301232. Can J Gastroenterol. 2006. PMID: 16779461 Free PMC article.
-
Sustained eradication of hepatitis C virus by low-dose long-term interferon therapy in a renal transplant recipient with dual infection with hepatitis B and C viruses: a case report.J Med Case Rep. 2011 Jun 29;5:246. doi: 10.1186/1752-1947-5-246. J Med Case Rep. 2011. PMID: 21714861 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
